Christine Lauren Benador-Shen, MD
Ophthalmology · Santa Clara
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 4
- 1 carrier
- Office
- 1
Offices
1 location · Permanente Medical Group Inc · 10,928 clinicians in this group
Plans that list them
4 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Benador-Shen’s office at (408) 851-1000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Kaiser Permanente Dual Complete North P2 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Dual Complete North P23 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Basic Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Enhanced Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
California Medical Board record
Licence A172384 · Current
Licensed to practise in California · since 2021 · expires 2027-04-30 · Northwestern University Feinberg School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Drugs they prescribed that Part D paid
$171,511
Pharmacies billed $171,511 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 750) in 2024. At or below the middle of the specialty; the typical ophthalmology clinician is at 0%.
570 generic and 180 brand-name prescriptions · $171,511 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Amjevita(Cf) | 22 | $65,236 | $2,965 |
| Rasuvo | 19 | $15,541 | $818 |
| Prednisolone Acetate | 113 | $6,076 | $54 |
| Difluprednate | 22 | $5,748 | $261 |
| Valganciclovir | 42 | $2,960 | $70 |
See all 15 drugs
| Amjevita(Cf) | 22 | $65,236 | $2,965 |
| Rasuvo | 19 | $15,541 | $818 |
| Prednisolone Acetate | 113 | $6,076 | $54 |
| Difluprednate | 22 | $5,748 | $261 |
| Valganciclovir | 42 | $2,960 | $70 |
| Dorzolamide-Timolol | 20 | $2,585 | $129 |
| Valacyclovir | 24 | $2,440 | $102 |
| Dorzolamide-Timolol | 101 | $2,203 | $22 |
| Latanoprost | 113 | $1,728 | $15 |
| Brimonidine | 66 | $1,198 | $18 |
| Timolol Maleate | 61 | $1,157 | $19 |
| Mycophenolate Mofetil | 11 | $897 | $82 |
| Methotrexate | 24 | $612 | $26 |
| Prednisone | 24 | $301 | $13 |
| Polymyxin B Sul-Trimethoprim | 13 | $160 | $12 |
Year by year
| 2024 | 750 | 189 | 0% (0) | 24% | $171,511 |
| 2023 | 1,344 | 311 | 0% (0) | None | $246,575 |
| 2022 | 634 | 200 | 0% (0) | None | $326,678 |
| 2021 | 276 | 111 | None | 38% | $86,156 |
| 2020 | 122 | 46 | None | 37% | $24,309 |
| 2019 | 301 | 98 | None | 32% | $50,481 |
| 2018 | 122 | 75 | 0% (0) | 42% | $22,158 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 21 drugs
| Amjevita(Cf) | 25 | $107,395 | $4,296 |
| Humira(Cf) | 11 | $55,550 | $5,050 |
| Prednisolone Acetate | 269 | $14,845 | $55 |
| Rasuvo | 16 | $11,763 | $735 |
| Difluprednate | 48 | $11,321 | $236 |
| Valganciclovir | 57 | $8,170 | $143 |
| Dorzolamide-Timolol | 28 | $4,772 | $170 |
| Mycophenolate Mofetil | 34 | $4,132 | $122 |
| Dorzolamide-Timolol | 117 | $2,744 | $23 |
| Latanoprost | 162 | $2,542 | $16 |
| Valacyclovir | 32 | $2,472 | $77 |
| Timolol Maleate | 78 | $1,560 | $20 |
| Brimonidine | 84 | $1,402 | $17 |
| Prednisone | 57 | $1,030 | $18 |
| Polymyxin B Sul-Trimethoprim | 82 | $957 | $12 |
| Methotrexate | 27 | $519 | $19 |
| Diclofenac | 32 | $456 | $14 |
| Ofloxacin | 21 | $440 | $21 |
| Dorzolamide | 13 | $388 | $30 |
| Ketorolac Tromethamine | 14 | $250 | $18 |
| Moxifloxacin | 12 | $149 | $12 |
2022: 15 drugs
| Humira(Cf) | 24 | $159,170 | $6,632 |
| Valganciclovir | 21 | $12,442 | $592 |
| Rhopressa | 11 | $6,490 | $590 |
| Prednisolone Acetate | 94 | $5,806 | $62 |
| Difluprednate | 18 | $4,685 | $260 |
| Valacyclovir | 26 | $3,598 | $138 |
| Mycophenolate Mofetil | 13 | $3,372 | $259 |
| Dorzolamide-Timolol | 47 | $1,797 | $38 |
| Methotrexate | 37 | $1,222 | $33 |
| Brimonidine | 42 | $838 | $20 |
| Prednisone | 38 | $583 | $15 |
| Timolol Maleate | 24 | $448 | $19 |
| Latanoprost | 29 | $414 | $14 |
| Polymyxin B Sul-Trimethoprim | 17 | $180 | $11 |
| Erythromycin | 13 | $175 | $13 |
2021: 9 drugs
| Restasis | 18 | $16,229 | $902 |
| Durezol | 15 | $3,178 | $212 |
| Prednisolone Acetate | 31 | $1,703 | $55 |
| Latanoprost | 14 | $747 | $53 |
| Dorzolamide-Timolol | 21 | $542 | $26 |
| Methotrexate | 13 | $525 | $40 |
| Prednisone | 31 | $458 | $15 |
| Erythromycin | 25 | $330 | $13 |
| Brimonidine | 11 | $303 | $28 |
2020: 4 drugs
| Restasis | 19 | $18,826 | $991 |
| Latanoprost | 22 | $777 | $35 |
| Timolol Maleate | 15 | $363 | $24 |
| Erythromycin | 14 | $202 | $14 |
2019: 8 drugs
| Restasis | 20 | $21,708 | $1,085 |
| Timolol Maleate | 45 | $3,664 | $81 |
| Brimonidine | 18 | $2,572 | $143 |
| Prednisolone Acetate | 23 | $1,531 | $67 |
| Latanoprost | 55 | $1,529 | $28 |
| Dorzolamide | 19 | $1,238 | $65 |
| Dorzolamide-Timolol | 30 | $1,088 | $36 |
| Levobunolol | 11 | $184 | $17 |
2018: 2 drugs
| Timolol Maleate | 16 | $781 | $49 |
| Latanoprost | 20 | $771 | $39 |
Money from drug and device companies
$95 in 2023
| 2023 | 1 | 1 | None | $95 |
| 2022 | 1 | 1 | None | $22 |
| 2021 | 1 | 1 | None | $20 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Bausch & Lomb Americas | Xipere | $95 | 1 payment
|
See the published payment
| Bausch & Lomb Americas | Meals · 2023-12-01 | Xipere | $95 |
See earlier years (2022, 2021)
2022: $22
| Regeneron Healthcare Solutions | Evkeeza | $22 | 1 payment
|
2021: $20
| E.R. Squibb & Sons L.L.C. | Eliquis | $20 | 1 payment
|
Professional record
- NPI
- 1710370424
- Licence
- CA A172384California A172384: Current · expires 2027-04-30
- Trained
- Northwestern University Feinberg Medical School, 2017
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207W00000X (207W00000X)
- Mailing address
- 710 Lawrence Expy, Santa Clara, CA, 95051
- NPI first listed
- 2015-03-05
- NPI last updated
- 2022-09-01
- NPI record certified
- 2022-09-01
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 800 Washington St, Boston, MA, 02111 · 490 Illinois Street, San Francisco, CA, 94107
This office lists an electronic records connection.